Gueishan, Taiwan

Cheng-Lung Hsu



Average Co-Inventor Count = 1.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Gueishan Township, Taoyuan County, TW (2019)
  • Taoyuan, TW (2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Cheng-Lung Hsu: Innovator in Cancer Treatment and Androgen Receptor Function

Introduction

Cheng-Lung Hsu is a notable inventor based in Gueishan, Taiwan. He has made significant contributions to the fields of cancer treatment and androgen receptor-related diseases. With a total of 2 patents, his work focuses on innovative methods that enhance treatment options for patients.

Latest Patents

One of Hsu's latest patents is a method for evaluating whether an individual with cancer is suitable for treatment with a CDK inhibitor. This method involves detecting the copy number of specific genes from an in vitro sample, calculating a copy number variation ratio, and determining the suitability for administering the CDK inhibitor based on this ratio. Another significant patent involves the use of minoxidil for suppressing androgen receptor function. This patent outlines methods for treating androgen receptor-related diseases and acne by administering an effective amount of minoxidil.

Career Highlights

Cheng-Lung Hsu has worked at prominent institutions such as Chang Gung Memorial Hospital in Linkou and Chanel University. His experience in these organizations has contributed to his expertise in medical research and innovation.

Collaborations

Hsu has collaborated with various professionals in his field, including his coworker Hsin-Pai Li. These collaborations have likely enhanced his research and development efforts.

Conclusion

Cheng-Lung Hsu is a distinguished inventor whose work in cancer treatment and androgen receptor function showcases his commitment to advancing medical science. His innovative patents reflect his dedication to improving patient outcomes through research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…